Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
McKinsey
Boehringer Ingelheim
Harvard Business School
Mallinckrodt

Last Updated: December 7, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: lisdexamfetamine dimesylate


Email this page to a colleague

« Back to Dashboard

lisdexamfetamine dimesylate

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Takeda Pharms Usa VYVANSE lisdexamfetamine dimesylate CAPSULE;ORAL 021977 NDA Takeda Pharmaceuticals America, Inc. 59417-101-10 100 CAPSULE in 1 BOTTLE (59417-101-10) 2014-08-30
Takeda Pharms Usa VYVANSE lisdexamfetamine dimesylate CAPSULE;ORAL 021977 NDA Takeda Pharmaceuticals America, Inc. 59417-102-10 100 CAPSULE in 1 BOTTLE (59417-102-10) 2007-12-10
Takeda Pharms Usa VYVANSE lisdexamfetamine dimesylate CAPSULE;ORAL 021977 NDA Takeda Pharmaceuticals America, Inc. 59417-103-10 100 CAPSULE in 1 BOTTLE (59417-103-10) 2007-02-23
Takeda Pharms Usa VYVANSE lisdexamfetamine dimesylate CAPSULE;ORAL 021977 NDA Takeda Pharmaceuticals America, Inc. 59417-104-10 100 CAPSULE in 1 BOTTLE (59417-104-10) 2007-12-10
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Boehringer Ingelheim
Johnson and Johnson
McKesson
Mallinckrodt